Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
09/19/2013 | US20130245090 Identification of novel genes coding for small temporal rnas |
09/19/2013 | US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha |
09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
09/19/2013 | US20130244990 Genetic polymorphisms associated with depression |
09/19/2013 | US20130244964 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections |
09/19/2013 | US20130244950 Combination therapy for chemoresistant cancers |
09/19/2013 | US20130244936 Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence |
09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
09/19/2013 | US20130244908 Chemical sensor array having multiple sensors per well |
09/19/2013 | US20130244905 Reporter for RNA Polymerase II Termination |
09/19/2013 | US20130244903 Modulators of alpha-synuclein toxicity |
09/19/2013 | US20130244902 Early detection of pancreatic cancer |
09/19/2013 | US20130244901 Method and system for prognosis and treatment of diseases using portfolio of genes |
09/19/2013 | US20130244900 Gene Expression Profiling in Primary Ovarian Serous Papiliary Tumors and Normal Ovarian Epithelum |
09/19/2013 | US20130244899 Detecting infection in reduced pressure wound treatment |
09/19/2013 | US20130244897 Marker Sequences for Multiple Sclerosis and Use Thereof |
09/19/2013 | US20130244896 In vitro method for predicting whether a compound is genotoxic in vivo |
09/19/2013 | US20130244894 Nucleic acid-based authentication codes |
09/19/2013 | US20130244893 Methods And Compositions For The Diagnosis And Treatment Of Cancer Resistant To Anaplastic Lymphoma Kinase (ALK) Kinase Inhibitors |
09/19/2013 | US20130244890 Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer |
09/19/2013 | US20130244888 Compositions and methods for nucleotide sequencing |
09/19/2013 | US20130244887 Rapid genotyping analysis and devices thereof |
09/19/2013 | US20130244886 Compositions and methods for sequencing nucleic acids |
09/19/2013 | US20130244885 High-throughput sequencing method for methylated dna and use thereof |
09/19/2013 | US20130244884 Methods for Nucleotide Sequencing and High Fidelity Polynucleotide Synthesis |
09/19/2013 | US20130244882 Multiplex nucleic acid reactions |
09/19/2013 | US20130244340 Nanopore Based Molecular Detection and Sequencing |
09/19/2013 | US20130244333 Biological markers for longevity and diseases and uses thereof |
09/19/2013 | US20130244318 Automated Transient Image Cytometry |
09/19/2013 | US20130244317 Flow Cytometer Sorter |
09/19/2013 | US20130244316 Paper strip for determining minimum inhibitory concentrations of antibiotics |
09/19/2013 | US20130244286 COMPOSITIONS AND METHODS FOR cDNA SYNTHESIS |
09/19/2013 | US20130244270 Microfluidic device for cell motility screening and chemotaxis testing |
09/19/2013 | US20130244264 Measurement Method Using Enzyme |
09/19/2013 | US20130244256 Compositions and Methods for Treating and Diagnosing Cancer |
09/19/2013 | US20130244254 T1r hetero-oligomeric taste receptors |
09/19/2013 | US20130244247 Strains of saccharomyces cerevisiae |
09/19/2013 | US20130244244 Predicting allergic reactions |
09/19/2013 | US20130244241 Test Cartridge With Integrated Transfer Module |
09/19/2013 | US20130244240 Systems and methods for monitoring the amplification and dissociation behavior of dna molecules |
09/19/2013 | US20130244237 Methods and Compositions for Discrimination Between Cytosine and Modifications Thereof and for Methylome Analysis |
09/19/2013 | US20130244235 Methods and materials for noninvasive detection of colorectal neoplasia associated with inflammatory bowel disease |
09/19/2013 | US20130244233 Methods and Materials for Determining Pain Sensitivity and Predicting and Treating Related Disorders |
09/19/2013 | US20130244232 High-efficiency catalysts, preparation and use thereof |
09/19/2013 | US20130244230 Methods and means for characterizing antibiotic resistance in microorganisms |
09/19/2013 | US20130244223 Respiratory syncytial virus (rsv) viral load detection assay |
09/19/2013 | US20130244222 Lipoparticles comprising ion channels, methods of making and using the same |
09/19/2013 | US20130244221 Method for isolating hepatitis a virus or spring viremia of carp virus |
09/19/2013 | US20130243879 Platelet rich plasma formulations and use thereof |
09/19/2013 | US20130243813 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
09/19/2013 | US20130243803 Therapies, vaccines, and predictive methods for infectious salmon anemia virus |
09/19/2013 | US20130243799 Novel cancer-associated antigen |
09/19/2013 | US20130243796 Genetic products differentially expressed in tumors and use thereof |
09/19/2013 | US20130243794 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses |
09/19/2013 | US20130243787 Predicting TGF-beta Therapeutic Responses |
09/19/2013 | US20130243736 Replacement of bone marrow niche cells for treatment of various diseases |
09/19/2013 | US20130243713 Skin and Hair Color-Controlling Factor |
09/19/2013 | US20130243656 Methods for uniform metal impregnation into a nanoporous material |
09/19/2013 | US20130240375 Method for determining hematocrit corrected analyte concentrations |
09/19/2013 | US20130240374 Glucose Dehydrogenase/Cytochrome Fusion Protein |
09/19/2013 | DE102012215925B3 Zeitgleicher Nachweis verschiedener microRNA-Biogenese-Formen Simultaneous detection of different microRNA biogenesis forms |
09/19/2013 | DE102012005153A1 Diagnosing malignant diseases e.g. lung and pancreatic cancers, comprises providing a sample obtained from a bodily fluid or a bodily excretion, and determining the concentration of small nuclear RNA RNU2-1 or their fragments in the sample |
09/18/2013 | EP2639586A1 Measurement method using enzymes |
09/18/2013 | EP2639319A2 Genetic polymorphisms associated with Psoriasis, methods of detection and uses thereof |
09/18/2013 | EP2639318A2 Genetic polymorphisms associated with Psoriasis, methods of detection and uses thereof |
09/18/2013 | EP2639317A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
09/18/2013 | EP2639316A1 Biomarkers for melanoma |
09/18/2013 | EP2639315A1 Biomarkers for melanoma |
09/18/2013 | EP2639314A1 In vitro method for predicting whether a compound is genotoxic in vivo. |
09/18/2013 | EP2639313A1 High-resolution transcriptome of human macrophages |
09/18/2013 | EP2639312A1 Immunoassay for detection of specific nucleic acid sequences such as miRNAs |
09/18/2013 | EP2639311A1 Genetic testing method and testing apparatus |
09/18/2013 | EP2639310A1 Method for quantification of remnant-like lipoprotein cholesterol and kit for same |
09/18/2013 | EP2639305A1 Markers for detecting human follicular helper t cells and method for detecting human follicular helper t cells |
09/18/2013 | EP2639304A1 Method for detecting nucleic acid, method for optically observing sample, and phosphor |
09/18/2013 | EP2638403A2 Bin1 expression as a marker of skeletal muscle mass and neurological conditions |
09/18/2013 | EP2638402A2 Detection of adenylate cyclase |
09/18/2013 | EP2638398A1 Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder |
09/18/2013 | EP2638396A2 Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells |
09/18/2013 | EP2638178A2 Compositions, methods, and kits for detecting and identifying mycobacteria |
09/18/2013 | EP2638177A2 Classification of nucleic acid templates |
09/18/2013 | EP2638176A1 Enrichment and identification of fetal cells in maternal blood and ligands for such use |
09/18/2013 | EP2638175A1 Method for the selection of compounds useful for the treatment of psychiatric and neurodegenerative diseases |
09/18/2013 | EP2638174A2 Method of detecting and serotyping of pathogens in a sample |
09/18/2013 | EP2638164A1 Specific ligand for annexin 2 |
09/18/2013 | EP2638160A2 Nuclions and ribocapsids |
09/18/2013 | EP2638156A1 Method and device for isolating and purifying double-stranded nucleic acids |
09/18/2013 | EP2638150A1 Recombinant p4 bacteriophage and methods for their use |
09/18/2013 | EP2638052A1 Selective glycosidase inhibitors and uses thereof |
09/18/2013 | EP2637560A2 Temperature sensing analyte sensors, systems, and methods of manufacturing and using same |
09/18/2013 | EP2418287B1 Nucleic acid amplification primers for PCR-based clonality studies of the TCR-beta gene |
09/18/2013 | CN203200273U Quick chicken gender identification kit |
09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
09/18/2013 | CN103314383A In vitro diagnostic testing including automated brokering of royalty payments for proprietary tests |
09/18/2013 | CN103314298A Novel marker for detection of bladder cancer and/or inflammatory conditions of the bladder |
09/18/2013 | CN103314290A Eluent for ion-exchange chromatography, and method of analyzing nucleic acid chains |
09/18/2013 | CN103314117A Diagnostic transcript and splice patterns of HR-HPV in different cervical lesions |
09/18/2013 | CN103314116A Methods for diagnosing and treating eye-length related disorders |
09/18/2013 | CN103314115A Methods and compositions for modified ethanol inducible promoter systems |
09/18/2013 | CN103314114A Epigenetic markers of colorectal cancers and diagnostic methods using the same |